Concert Genetics has released its comprehensive genetic test identification system for use in the market to streamline automation in test ordering, coverage, payment, and clinical decision support.
Read More
The urine test, which is expected to be available by mid-2022, will use highly sensitive liquid biopsy technology developed by Nonacus and a panel of biomarkers validated by Birmingham University researchers to diagnose bladder cancer.
Read More
Seegene announced that it has signed a partnership with Bio-Rad for the development of infectious disease molecular diagnostic products.
Read More
A team at the UCLA school of medicine and school of engineering developed a high-throughput platform to test thousands of COVID-19 samples.
Read More
Thermo Fisher Scientific has launched a CE-IVD-marked COVID-19 test. The TaqPath COVID-19 Fast PCR Combo Kit 2.0.
Read More